Utilization of Rehabilitation Services in Stroke: A Study Utilizing the Health and Retirement Study With Linked Medicare Claims Data.


Journal

Archives of physical medicine and rehabilitation
ISSN: 1532-821X
Titre abrégé: Arch Phys Med Rehabil
Pays: United States
ID NLM: 2985158R

Informations de publication

Date de publication:
12 2019
Historique:
received: 07 08 2018
revised: 14 06 2019
accepted: 23 06 2019
pubmed: 20 8 2019
medline: 14 4 2020
entrez: 18 8 2019
Statut: ppublish

Résumé

To describe Medicare fee-for-service beneficiaries who used poststroke rehabilitation services and identified the strongest predictors of utilization after the initial stroke care episode. Pooled, cross-sectional design using data from 1998 to 2010 from the Health and Retirement Study (HRS) with linked Medicare claims data. NA. Stroke survivors who were Medicare fee-for-service beneficiaries and participated in the HRS were included (N=515). Utilization of rehabilitation services up to 10 years poststroke was the primary outcome with logistic regression used to predict utilization. Covariates included demographic factors, baseline functional status, health conditions, personal lifestyle factors, and social support. Rehabilitation service utilization was 21.6%, 6.8%, 15.8%, 16.5%, and <16% in years 2, 4, 6, 8, and 10, respectively. Age was the primary factor predicting use of rehabilitation in the first 10 years poststroke (odds ratio: 1.14; P=.001). Recurrent stroke (odds ratio: 1.64; P=.051) was also significantly associated with utilization, whereas unspecified incident stroke at incident trended toward significance (odds ratio: 2.17; P=.077). None of the other factors was a significant predictor of participation in rehabilitation services in this period. A small number of Medicare fee-for-service beneficiaries who are stroke survivors utilize rehabilitation services in the first 10 years poststroke. Of those who do, age is the primary driver of utilization. We analyzed a multitude of factors that might influence utilization, but other factors not available in these data also need to be explored.

Identifiants

pubmed: 31421093
pii: S0003-9993(19)30977-3
doi: 10.1016/j.apmr.2019.06.017
pmc: PMC7739196
mid: NIHMS1626773
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2244-2250

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States

Informations de copyright

Copyright © 2019 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Références

Disabil Rehabil. 2002 Oct 15;24(15):774-85
pubmed: 12437863
Arch Phys Med Rehabil. 2011 Nov;92(11):1802-8
pubmed: 22032214
J Allied Health. 2005 Spring;34(1):3-10
pubmed: 15839599
MMWR Morb Mortal Wkly Rep. 2007 May 25;56(20):504-7
pubmed: 17522589
Arch Phys Med Rehabil. 2018 Jun;99(6):1077-1089.e7
pubmed: 28389108
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:100-28
pubmed: 22262598
Stroke. 2010 May;41(5):1051-65
pubmed: 20181677
Clin Rehabil. 2002 Mar;16(2):149-59
pubmed: 11911513
Stroke. 2016 Jun;47(6):e98-e169
pubmed: 27145936
J Rehabil Med. 2004 Jul;(44 Suppl):135-41
pubmed: 15370761
Br J Anaesth. 2010 Apr;104(4):459-64
pubmed: 20185517
Health Soc Care Community. 2003 Sep;11(5):405-14
pubmed: 14498837
Phys Ther. 2006 Oct;86(10):1342-50
pubmed: 17012638
Phys Ther. 2015 Dec;95(12):1660-7
pubmed: 26089042
J Gerontol B Psychol Sci Soc Sci. 2007 May;62(3):S169-78
pubmed: 17507592
Arch Phys Med Rehabil. 2002 Jun;83(6):837-45
pubmed: 12048664
Am J Phys Med Rehabil. 2006 Mar;85(3):192-200
pubmed: 16505634
Arch Phys Med Rehabil. 2018 Jun;99(6):1232-1241
pubmed: 28947162
Brain Inj. 2015;29(6):701-8
pubmed: 25789712
Am J Prev Med. 2006 Jul;31(1):25-31
pubmed: 16777539
Ann Fam Med. 2012 Mar-Apr;10(2):134-41
pubmed: 22412005
PLoS One. 2018 Feb 23;13(2):e0192911
pubmed: 29474391
J Gerontol B Psychol Sci Soc Sci. 2005 Oct;60 Spec No 2:85-92
pubmed: 16251597
Lancet. 2004 Jan 31;363(9406):352-6
pubmed: 15070563
Stroke. 2011 Jul;42(7):2091-116
pubmed: 21617147
Stroke. 2010 Oct;41(10):2402-48
pubmed: 20813995

Auteurs

Karen M Keptner (KM)

School of Medicine, Case Western Reserve University, Cleveland, OH. Electronic address: k.keptner@csuohio.edu.

Kathleen Smyth (K)

School of Medicine, Case Western Reserve University, Cleveland, OH.

Siran Koroukian (S)

School of Medicine, Case Western Reserve University, Cleveland, OH.

Mark Schluchter (M)

School of Medicine, Case Western Reserve University, Cleveland, OH.

Anthony Furlan (A)

School of Medicine, Case Western Reserve University, Cleveland, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH